Neil Gunn insider trades
Open-market stock purchases and sales by Neil Gunn, Director at Neogenomics Inc, from SEC Form 4 filings since Aug 10, 2023.
Track record: 100% of 1 scored buy are up 5% or more since purchase, averaging +114%.
Companies traded
- NEO Neogenomics Inc: 1 buy, last Jun 1, 2026